Sunitinib-induced cardiac hypertrophy and the endothelin axis
Joevin Sourdon(Délégation Paris 5), Bertrand Tavitian(Inserm), Thomas Viel(Inserm), Judith Favier(Inserm), Blaise Robin(Inserm), Daniel Balvay(Délégation Paris 5), Gilles Renault(Centre National de la Recherche Scientifique), Franck Lager(Inserm), Carmen Marchiol(Centre National de la Recherche Scientifique), Pierre‐Louis Tharaux(Inserm), Neeraj Dhaun(University of Edinburgh), Caterina Facchin(Inserm), Thulaciga Yoganathan(Enzo Life Sciences (United States)), Anaïs Certain(Inserm)
Cited by 20
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772